208 related articles for article (PubMed ID: 10682068)
1. Evaluation of the effect of uremia on peritoneal permeability in an experimental model of continuous ambulatory peritoneal dialysis in anephric rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos D
Adv Perit Dial; 1999; 15():32-5. PubMed ID: 10682068
[TBL] [Abstract][Full Text] [Related]
2. Short peritoneal equilibration test: impact of preceding dwell time.
Twardowski ZJ; Prowant BF; Moore HL; Lou LC; White E; Farris K
Adv Perit Dial; 2003; 19():53-8. PubMed ID: 14763034
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis.
Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2001; 17():42-6. PubMed ID: 11510294
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of peritoneal equilibration test (PET) in rats.
Wieczorowska K; Khanna R; Moore HL; Nolph KD; Twardowski ZJ
Adv Perit Dial; 1994; 10():33-7. PubMed ID: 7999859
[TBL] [Abstract][Full Text] [Related]
5. Results of peritoneal equilibration test during treatment with polyglucose dialysis solution.
Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M
Perit Dial Int; 2002; 22(3):357-64. PubMed ID: 12227394
[TBL] [Abstract][Full Text] [Related]
6. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
[TBL] [Abstract][Full Text] [Related]
7. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
[TBL] [Abstract][Full Text] [Related]
8. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
[TBL] [Abstract][Full Text] [Related]
9. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
Połubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal hyaluronan administration in conscious rats: absorption, metabolism, and effects on peritoneal fluid dynamics.
Breborowicz A; Polubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Moberly J; Martis L; Oreopoulos D
Perit Dial Int; 2001; 21(2):130-5. PubMed ID: 11330555
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
Rodrigues A; Cabrita A; Maia P; Guimarães S
Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients.
Passadakis P; Panagoutsos S; Thodis E; Tsivara I; Sopassi F; Kartali S; Vargemezis V
Adv Perit Dial; 1999; 15():40-4. PubMed ID: 10682070
[TBL] [Abstract][Full Text] [Related]
13. [Peritoneal blood flow, peritoneal transfer and continuous ambulatory peritoneal dialysis].
Grzegorzewska A; Sliwowski A
Pol Merkur Lekarski; 1997 Sep; 3(15):122-5. PubMed ID: 9461708
[TBL] [Abstract][Full Text] [Related]
14. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
Grzegorzewska AE; Leander M; Mariak I
Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
[TBL] [Abstract][Full Text] [Related]
15. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
16. Influence of the preceding exchange on peritoneal equilibration test results.
Figueiredo AE; Conti A; Poli de Figueiredo CE
Adv Perit Dial; 2002; 18():75-7. PubMed ID: 12402592
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal pressure, peritoneal permeability and volume of ultrafiltration in CAPD.
Durand PY; Chanliau J; Gamberoni J; Hestin D; Kessler M
Adv Perit Dial; 1992; 8():22-5. PubMed ID: 1361791
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of the peritoneal equilibration test and ultrafiltration in patients with and without diabetes mellitus on continuous ambulatory peritoneal dialysis.
Chou MY; Kao MT; Lai MN; Chung SY
Am J Nephrol; 2006; 26(1):87-90. PubMed ID: 16543711
[TBL] [Abstract][Full Text] [Related]
19. Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat.
Pedersen TF; Nielsen AH; Strandgaard S; Paulson OB
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):130-4. PubMed ID: 12228855
[TBL] [Abstract][Full Text] [Related]
20. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
